Synergistic effect of AS101 and Bryostatin-1 on myeloid leukemia cell differentiation in vitro and in an animal model

M. Hayun, E. Okun, R. Hayun, U. Gafter, M. Albeck, D. L. Longo, B. Sredni*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


We evaluated the synergistic activity of AS101 (ammonium trichloro-(dioxoethylene-0-0′)-tellurate) with the protein kinase C (PKC) activators, Bryostatin-1 and phorbol-12-myristate-13-acetate (PMA), on human myelocytic leukemia cell differentiation in vitro, and in a mouse model. Use of AS101 with Bryostatin-1 or with a low concentration of PMA resulted in the differentiation of HL-60 cell line to cells with characteristics of macrophages. A similar synergistic effect was found in vivo. Compared with mice treated with AS101 alone or with Bryostatin-1 alone, the infiltration of leukemic cells into the spleen and the peritoneum of mice treated with both compounds, as well as the number of the HL-60 colonies extracted from those organs, were markedly reduced. The antitumor effects were associated with significantly prolonged survival (100% for 125 days) of the treated mice. Finally, the mechanism of action of this antitumor effect was explored, and was found to involve the Ras/extracellular signal-regulated kinase signaling pathway. Combined treatment with AS101 and Bryostatin-1 synergistically increased p21waf1 expression levels independently of p53. Upregulation of p21waf1 was necessary for HL-60 cell differentiation, which was found to be both c-raf-1 and mitogen-activated protein kinase dependent. This study may have implications for the development of strategies to induce differentiation in myeloid leukemias, myelodysplasias and possibly in other malignancies.

Original languageEnglish
Pages (from-to)1504-1513
Number of pages10
Issue number7
StatePublished - Jul 2007
Externally publishedYes


FundersFunder number
Safdié Institute for AIDS and Immunology Research
National Institutes of Health
National Institute on Aging


    Dive into the research topics of 'Synergistic effect of AS101 and Bryostatin-1 on myeloid leukemia cell differentiation in vitro and in an animal model'. Together they form a unique fingerprint.

    Cite this